It is recognised it may be difficult to diagnose pulmonary arterial hypertension (PAH) because symptoms may be non-specific in the early stages.<\/p>
<\/p>
NHS England has published service specifications for PAH centres and shared care centres which provide services closer to patients\u2019 homes. These specifications clearly define the standards of care expected from organisations funded by NHS England to provide specialised care to PAH patients. Last year all PAH centres met the National Standard on timely diagnosis by having over 95% of patients receive a recorded diagnosed within six months of referral.<\/p>
<\/p>
The information requested on the number of clinical commissioning groups that provide PAH services is not centrally held.<\/p>
<\/p>
The information requested on the number of cases for PAH is not centrally held, as the Hospital Episode Statistics (HES) database contains records of hospital episodes and attendances rather than people.<\/p>
<\/p>
A count of finished admission episodes (FAEs) with a primary diagnosis or a primary or secondary diagnosis of pulmonary arterial hypertension, 2014-15 to 2016-17 is as follows:<\/p>
<\/p>
Activity in English National Health Service Hospitals and English NHS commissioned activity in the independent sector<\/p>
<\/p>
Year<\/p><\/td> | Primary diagnosis<\/p><\/td> | Primary or secondary diagnosis<\/p><\/td><\/tr> | |||||||||||||||||||||||||||
2014-15<\/p><\/td> | 7,149<\/p><\/td> | 42,160<\/p><\/td><\/tr> | |||||||||||||||||||||||||||
2015-16<\/p><\/td> | 7,447<\/p><\/td> | 46,293<\/p><\/td><\/tr> | |||||||||||||||||||||||||||
2016-17<\/p><\/td> | 7,418<\/p><\/td> | 49,558<\/p><\/td><\/tr> | |||||||||||||||||||||||||||
Source: HES, NHS Digital<\/p><\/td> | <\/p><\/td><\/tr><\/tbody><\/table> <\/p> Counts of FAEs1<\/sup> with a primary diagnosis2<\/sup> or a primary or secondary diagnosis3<\/sup> of pulmonary arterial hypertension4<\/sup>, 2014-15 to 2016-175<\/sup><\/p> <\/p> Notes:<\/p> <\/sup><\/p> 1<\/sup>FAEs<\/p> A FAE is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.<\/p> <\/p> 2<\/sup>Primary diagnosis<\/p> The primary diagnosis is the first of up to 20 (14 from 2002-03 to 2006-07 and seven prior to 2002-03) diagnosis fields in the HES data set and provides the main reason why the patient was admitted to hospital.<\/p> <\/p> 3<\/sup>Primary or secondary diagnosis<\/p> The number of episodes where this diagnosis was recorded in any of the 20 (14 from 2002-03 to 2006-07 and seven prior to 2002-03) primary and secondary diagnosis fields in a HES record. Each episode is only counted once, even if the diagnosis is recorded in more than one diagnosis field of the record.<\/p> <\/p> 4<\/sup>ICD-10 Codes used<\/p> The following ICD-10 diagnosis codes were used to define pulmonary arterial hypertension: I27.2 Other secondary pulmonary hypertension<\/p> <\/p> 5<\/sup>Assessing growth through time (Admitted patient care)<\/p> HES figures are available from 1989-90 onwards. Changes to the figures over time need to be interpreted in the context of improvements in data quality and coverage (particularly in earlier years), improvements in coverage of independent sector activity (particularly from 2006-07) and changes in NHS practice. For example, apparent reductions in activity may be due to a number of procedures which may now be undertaken in outpatient settings and so no longer include in admitted patient HES data. Conversely, apparent increases in activity may be due to improved recording of diagnosis or procedure information.<\/p> <\/p> It should be noted that HES include activity ending in the year in question and run from April to March, e.g. 2012-13 includes activity ending between 1 April 2012 and 31 March 2013.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-19", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "131780"}
, {"_value" : "131781"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-19T11:30:15.73Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pulmonary Arterial Hypertension"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many cases there were of pulmonary arterial hypertension in England in each of the last 3 years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "131777"}
, {"_about" : "http://data.parliament.uk/resources/858524", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/858524/answer", "answerText" : {"_value" : " NHS England commissions work on specialised Pulmonary Hypertension (PH) through the Specialised Respiratory Clinical Reference Group (CRG) which is delivered through regional specialised commissioning teams.<\/p> <\/p> The CRG is chaired by Professor Mike Morgan, NHS England\u2019s National Clinical Director for Respiratory Disease. The CRG and commissioners actively engage with PH clinicians and the patient community in supporting policy development. The Pulmonary Hypertension Association was encouraged to apply both as patient voice members and to register as a stakeholder to the CRG.<\/p> <\/p> NHS England has published a service specification which sets out what the related centre and shared care model should look like. In the last year, NHS England has completed a peer review of this service and local commissioning leads are following up with each hospital service identified for improvement.<\/p> <\/p> NHS England also commissions the National Audit of Pulmonary Hypertension which covers the care of patients treated by the pulmonary hypertension services in eight United Kingdom centres.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-14", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "131402"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-14T15:47:33.923Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pulmonary Arterial Hypertension"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, which body is responsible for commissioning treatments and services for patients with pulmonary hypertension.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "131779"}
, {"_about" : "http://data.parliament.uk/resources/858525", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/858525/answer", "answerText" : {"_value" : " It is recognised it may be difficult to diagnose pulmonary arterial hypertension (PAH) because symptoms may be non-specific in the early stages.<\/p> <\/p> NHS England has published service specifications for PAH centres and shared care centres which provide services closer to patients\u2019 homes. These specifications clearly define the standards of care expected from organisations funded by NHS England to provide specialised care to PAH patients. Last year all PAH centres met the National Standard on timely diagnosis by having over 95% of patients receive a recorded diagnosed within six months of referral.<\/p> <\/p> The information requested on the number of clinical commissioning groups that provide PAH services is not centrally held.<\/p> <\/p> The information requested on the number of cases for PAH is not centrally held, as the Hospital Episode Statistics (HES) database contains records of hospital episodes and attendances rather than people.<\/p> <\/p> A count of finished admission episodes (FAEs) with a primary diagnosis or a primary or secondary diagnosis of pulmonary arterial hypertension, 2014-15 to 2016-17 is as follows:<\/p> <\/p> Activity in English National Health Service Hospitals and English NHS commissioned activity in the independent sector<\/p> <\/p> Year<\/p><\/td> Primary diagnosis<\/p><\/td> Primary or secondary diagnosis<\/p><\/td><\/tr> 2014-15<\/p><\/td> 7,149<\/p><\/td> 42,160<\/p><\/td><\/tr> 2015-16<\/p><\/td> 7,447<\/p><\/td> 46,293<\/p><\/td><\/tr> 2016-17<\/p><\/td> 7,418<\/p><\/td> 49,558<\/p><\/td><\/tr> Source: HES, NHS Digital<\/p><\/td> <\/p><\/td><\/tr><\/tbody><\/table> <\/p> Counts of FAEs1<\/sup> with a primary diagnosis2<\/sup> or a primary or secondary diagnosis3<\/sup> of pulmonary arterial hypertension4<\/sup>, 2014-15 to 2016-175<\/sup><\/p> <\/p> Notes:<\/p> <\/sup><\/p> 1<\/sup>FAEs<\/p> A FAE is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.<\/p> <\/p> 2<\/sup>Primary diagnosis<\/p> The primary diagnosis is the first of up to 20 (14 from 2002-03 to 2006-07 and seven prior to 2002-03) diagnosis fields in the HES data set and provides the main reason why the patient was admitted to hospital.<\/p> <\/p> 3<\/sup>Primary or secondary diagnosis<\/p> The number of episodes where this diagnosis was recorded in any of the 20 (14 from 2002-03 to 2006-07 and seven prior to 2002-03) primary and secondary diagnosis fields in a HES record. Each episode is only counted once, even if the diagnosis is recorded in more than one diagnosis field of the record.<\/p> <\/p> 4<\/sup>ICD-10 Codes used<\/p> The following ICD-10 diagnosis codes were used to define pulmonary arterial hypertension: I27.2 Other secondary pulmonary hypertension<\/p> <\/p> 5<\/sup>Assessing growth through time (Admitted patient care)<\/p> HES figures are available from 1989-90 onwards. Changes to the figures over time need to be interpreted in the context of improvements in data quality and coverage (particularly in earlier years), improvements in coverage of independent sector activity (particularly from 2006-07) and changes in NHS practice. For example, apparent reductions in activity may be due to a number of procedures which may now be undertaken in outpatient settings and so no longer include in admitted patient HES data. Conversely, apparent increases in activity may be due to improved recording of diagnosis or procedure information.<\/p> <\/p> It should be noted that HES include activity ending in the year in question and run from April to March, e.g. 2012-13 includes activity ending between 1 April 2012 and 31 March 2013.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-19", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "131777"}
, {"_value" : "131781"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-19T11:30:15.807Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pulmonary Arterial Hypertension"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to decrease the average length of time that it takes to diagnose pulmonary arterial hypertension.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "131780"}
, {"_about" : "http://data.parliament.uk/resources/858526", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/858526/answer", "answerText" : {"_value" : " It is recognised it may be difficult to diagnose pulmonary arterial hypertension (PAH) because symptoms may be non-specific in the early stages.<\/p> <\/p> NHS England has published service specifications for PAH centres and shared care centres which provide services closer to patients\u2019 homes. These specifications clearly define the standards of care expected from organisations funded by NHS England to provide specialised care to PAH patients. Last year all PAH centres met the National Standard on timely diagnosis by having over 95% of patients receive a recorded diagnosed within six months of referral.<\/p> <\/p> The information requested on the number of clinical commissioning groups that provide PAH services is not centrally held.<\/p> <\/p> The information requested on the number of cases for PAH is not centrally held, as the Hospital Episode Statistics (HES) database contains records of hospital episodes and attendances rather than people.<\/p> <\/p> A count of finished admission episodes (FAEs) with a primary diagnosis or a primary or secondary diagnosis of pulmonary arterial hypertension, 2014-15 to 2016-17 is as follows:<\/p> <\/p> Activity in English National Health Service Hospitals and English NHS commissioned activity in the independent sector<\/p> <\/p> Year<\/p><\/td> Primary diagnosis<\/p><\/td> Primary or secondary diagnosis<\/p><\/td><\/tr> 2014-15<\/p><\/td> 7,149<\/p><\/td> 42,160<\/p><\/td><\/tr> 2015-16<\/p><\/td> 7,447<\/p><\/td> 46,293<\/p><\/td><\/tr> 2016-17<\/p><\/td> 7,418<\/p><\/td> 49,558<\/p><\/td><\/tr> Source: HES, NHS Digital<\/p><\/td> <\/p><\/td><\/tr><\/tbody><\/table> <\/p> Counts of FAEs1<\/sup> with a primary diagnosis2<\/sup> or a primary or secondary diagnosis3<\/sup> of pulmonary arterial hypertension4<\/sup>, 2014-15 to 2016-175<\/sup><\/p> <\/p> Notes:<\/p> <\/sup><\/p> 1<\/sup>FAEs<\/p> A FAE is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.<\/p> <\/p> 2<\/sup>Primary diagnosis<\/p> The primary diagnosis is the first of up to 20 (14 from 2002-03 to 2006-07 and seven prior to 2002-03) diagnosis fields in the HES data set and provides the main reason why the patient was admitted to hospital.<\/p> <\/p> 3<\/sup>Primary or secondary diagnosis<\/p> The number of episodes where this diagnosis was recorded in any of the 20 (14 from 2002-03 to 2006-07 and seven prior to 2002-03) primary and secondary diagnosis fields in a HES record. Each episode is only counted once, even if the diagnosis is recorded in more than one diagnosis field of the record.<\/p> <\/p> 4<\/sup>ICD-10 Codes used<\/p> The following ICD-10 diagnosis codes were used to define pulmonary arterial hypertension: I27.2 Other secondary pulmonary hypertension<\/p> <\/p> 5<\/sup>Assessing growth through time (Admitted patient care)<\/p> HES figures are available from 1989-90 onwards. Changes to the figures over time need to be interpreted in the context of improvements in data quality and coverage (particularly in earlier years), improvements in coverage of independent sector activity (particularly from 2006-07) and changes in NHS practice. For example, apparent reductions in activity may be due to a number of procedures which may now be undertaken in outpatient settings and so no longer include in admitted patient HES data. Conversely, apparent increases in activity may be due to improved recording of diagnosis or procedure information.<\/p> <\/p> It should be noted that HES include activity ending in the year in question and run from April to March, e.g. 2012-13 includes activity ending between 1 April 2012 and 31 March 2013.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-19", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "131777"}
, {"_value" : "131780"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-19T11:30:15.887Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pulmonary Arterial Hypertension"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many clinical commissioning groups offer pulmonary rehabilitation services for patients with pulmonary arterial hypertension.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "131781"}
, {"_about" : "http://data.parliament.uk/resources/858549", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/858549/answer", "answerText" : {"_value" : " The office of my Rt. hon. Friend the Secretary of State responded to the hon. Member on 8 February 2018. As their reply stated, my Rt. hon. Friend plans to visit Dewsbury, but dates are yet to be confirmed.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2018-03-14", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-14T12:21:41.333Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Members: Correspondence"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter of the 9 January 2018 from the hon Member for Dewsbury on visiting health care services in Dewsbury constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4426", "label" : {"_value" : "Biography information for Paula Sherriff"}
}
, "tablingMemberConstituency" : {"_value" : "Dewsbury"}
, "tablingMemberPrinted" : [{"_value" : "Paula Sherriff"}
], "uin" : "131804"}
, {"_about" : "http://data.parliament.uk/resources/858565", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/858565/answer", "answerText" : {"_value" : " The level of provision of infertility treatment is decided by local clinical commissioning groups (CCGs) and will take into account the needs of the population overall. NHS England has advised that it recognises that there is a great deal of interest in the quality and availability of in vitro fertilisation (IVF) services, and is developing a benchmark price that the National Health Service pays for fertility treatments, which will become available for use in 2018/19. NHS England is also working with CCGs and various stakeholders including the Human Fertilisation and Embryology Authority, to understand how best to help them commission IVF services.<\/p> <\/p> NHS England has advised that, because CCGs are responsible for the commissioning of IVF, it is essential that any support that is given is developed in partnership with them. That is why NHS England are now working with NHS clinical commissioners, the national member organisation for CCGs, to identify the best way of supporting CCGs. NHS England have advised that any guidance will be led by NHS clinical commissioners and will contribute to their work as appropriate.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2018-03-19", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "131821"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-19T11:36:24.13Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "IVF"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans he has to reduce the number of clinical commissioning groups that have decommissioned IVF services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/298", "label" : {"_value" : "Biography information for Steve McCabe"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Selly Oak"}
, "tablingMemberPrinted" : [{"_value" : "Steve McCabe"}
], "uin" : "131820"}
, {"_about" : "http://data.parliament.uk/resources/858566", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/858566/answer", "answerText" : {"_value" : " The level of provision of infertility treatment is decided by local clinical commissioning groups (CCGs) and will take into account the needs of the population overall. NHS England has advised that it recognises that there is a great deal of interest in the quality and availability of in vitro fertilisation (IVF) services, and is developing a benchmark price that the National Health Service pays for fertility treatments, which will become available for use in 2018/19. NHS England is also working with CCGs and various stakeholders including the Human Fertilisation and Embryology Authority, to understand how best to help them commission IVF services.<\/p> <\/p> NHS England has advised that, because CCGs are responsible for the commissioning of IVF, it is essential that any support that is given is developed in partnership with them. That is why NHS England are now working with NHS clinical commissioners, the national member organisation for CCGs, to identify the best way of supporting CCGs. NHS England have advised that any guidance will be led by NHS clinical commissioners and will contribute to their work as appropriate.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2018-03-19", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "131820"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-19T11:36:24.207Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "IVF"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans he has to introduce commissioning guidance on IVF services for clinical commissioning groups.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/298", "label" : {"_value" : "Biography information for Steve McCabe"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Selly Oak"}
, "tablingMemberPrinted" : [{"_value" : "Steve McCabe"}
], "uin" : "131821"}
, {"_about" : "http://data.parliament.uk/resources/858575", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/858575/answer", "answerText" : {"_value" : " Information on the number of adults and children diagnosed with fetal anti-convulsant syndrome in the United Kingdom due to pre-natal sodium valproate exposure is not collected centrally. Fetal anti-convulsant syndrome is a non-drug specific condition that relates to abnormalities in children exposed to any anticonvulsant, not just sodium valproate, during pregnancy.<\/p> <\/p> The Department does not collect data about local authorities' expenditure specifically on social care provision for children diagnosed with foetal anti-convulsant syndrome, or on the provision of special education needs or disability support for such children, and no estimate has been made by the Department of these costs.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2018-03-14", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "131831"}
, {"_value" : "131832"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-14T16:07:36.387Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Congenital Abnormalities"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care what information his Department holds on the number of (a) adults and (b) children diagnosed with fetal anti-convulsant syndrome in the UK as a result of mothers being prescribed with sodium valproate during pregnancy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "tablingMemberConstituency" : {"_value" : "North Norfolk"}
, "tablingMemberPrinted" : [{"_value" : "Norman Lamb"}
], "uin" : "131830"}
, {"_about" : "http://data.parliament.uk/resources/858577", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/858577/answer", "answerText" : {"_value" : " Information on the number of adults and children diagnosed with fetal anti-convulsant syndrome in the United Kingdom due to pre-natal sodium valproate exposure is not collected centrally. Fetal anti-convulsant syndrome is a non-drug specific condition that relates to abnormalities in children exposed to any anticonvulsant, not just sodium valproate, during pregnancy.<\/p> <\/p> The Department does not collect data about local authorities' expenditure specifically on social care provision for children diagnosed with foetal anti-convulsant syndrome, or on the provision of special education needs or disability support for such children, and no estimate has been made by the Department of these costs.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2018-03-14", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "131830"}
, {"_value" : "131831"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-14T16:07:36.51Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Congenital Abnormalities"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost of providing social care for children diagnosed with fetal anti-convulsant syndrome as a result of the mother being prescribed with sodium valproate during pregnancy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "tablingMemberConstituency" : {"_value" : "North Norfolk"}
, "tablingMemberPrinted" : [{"_value" : "Norman Lamb"}
], "uin" : "131832"}
, {"_about" : "http://data.parliament.uk/resources/858588", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/858588/answer", "answerText" : {"_value" : " The evaluation report on the national pilot on hospital trusts requesting two forms of identification from all patients commissioned by Ipsos Mori will be published in due course alongside the Department's proposed next steps and recommended approach.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4095", "label" : {"_value" : "Biography information for Steve Barclay"}
}
, "answeringMemberConstituency" : {"_value" : "North East Cambridgeshire"}
, "answeringMemberPrinted" : {"_value" : "Stephen Barclay"}
, "dateOfAnswer" : {"_value" : "2018-03-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-19T17:31:49Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Patients: Proof of Identity"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, when he plans to (a) publish the evaluation report on the national pilot on hospital trusts requesting two forms of identification from all patients and (b) provide guidance to NHS trusts on whether the practice will continue; whether that evaluation included consideration of whether the practice of requesting two forms of identity may (i) delay, (ii) deter or (iii) prevent patients who do not have proof of identity documents from accessing NHS care; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3930", "label" : {"_value" : "Biography information for Caroline Lucas"}
}
, "tablingMemberConstituency" : {"_value" : "Brighton, Pavilion"}
, "tablingMemberPrinted" : [{"_value" : "Caroline Lucas"}
], "uin" : "131843"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_page=1&max-ddpModified.=2018-03-12T11%3A36%3A05.472Z&max-answer.questionFirstAnswered.=2019-07-10T13%3A31%3A07.33Z", "page" : 0, "startIndex" : 1, "totalResults" : 1632, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|